Microsomal prostaglandin E synthase‐1 is involved in the metabolic and cardiovascular alterations associated with obesity
出版年份 2021 全文链接
标题
Microsomal prostaglandin E synthase‐1 is involved in the metabolic and cardiovascular alterations associated with obesity
作者
关键词
-
出版物
BRITISH JOURNAL OF PHARMACOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2021-12-08
DOI
10.1111/bph.15776
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Enzymes
- (2021) Stephen PH Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and Other Protein Targets
- (2021) Stephen PH Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
- (2021) Stephen PH Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Nuclear hormone receptors
- (2021) Stephen PH Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020
- (2020) Elliott Lilley et al. BRITISH JOURNAL OF PHARMACOLOGY
- mPGES-1 deletion attenuates isoproterenol-induced myocardial fibrosis in mice
- (2020) Shuang Ji et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
- (2020) Nathalie Percie du Sert et al. PLOS BIOLOGY
- A Representative GIIA Phospholipase A2 Activates Preadipocytes to Produce Inflammatory Mediators Implicated in Obesity Development
- (2020) Elbio Leiguez et al. Biomolecules
- Involvement of prostacyclin synthase in high-fat-diet-induced obesity
- (2020) Yuka Sasaki et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- The cyclooxygenase-1/mPGES-1/endothelial prostaglandin EP4 receptor pathway constrains myocardial ischemia-reperfusion injury
- (2019) Liyuan Zhu et al. Nature Communications
- A review on mPGES-1 inhibitors: From preclinical studies to clinical applications
- (2019) Filip Bergqvist et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers
- (2018) Michael J Curtis et al. BRITISH JOURNAL OF PHARMACOLOGY
- Obesity phenotypes and their paradoxical association with cardiovascular diseases
- (2018) Alessandra Vecchié et al. European Journal of Internal Medicine
- mPGES-1 (Microsomal Prostaglandin E Synthase-1) Mediates Vascular Dysfunction in Hypertension Through Oxidative StressNovelty and Significance
- (2018) María S. Avendaño et al. HYPERTENSION
- Mechanisms of Insulin Action and Insulin Resistance
- (2018) Max C. Petersen et al. PHYSIOLOGICAL REVIEWS
- The toxic effects of monosodium glutamate (MSG) – The involvement of nitric oxide, prostanoids and potassium channels in the reactivity of thoracic arteries in MSG-obese rats
- (2018) Michał Majewski et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Invalidation of Microsomal Prostaglandin E Synthase-1 (mPGES-1) Reduces Diet-Induced Low-Grade Inflammation and Adiposity
- (2018) Clément Pierre et al. Frontiers in Physiology
- Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk
- (2016) Jennifer H. Stern et al. Cell Metabolism
- Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease
- (2016) José J. Fuster et al. CIRCULATION RESEARCH
- Importance of adipocyte cyclooxygenase-2 and prostaglandin E2–prostaglandin E receptor 3 signaling in the development of obesity-induced adipose tissue inflammation and insulin resistance
- (2016) Pei-Chi Chan et al. FASEB JOURNAL
- Prostaglandin E2 Exerts Multiple Regulatory Actions on Human Obese Adipose Tissue Remodeling, Inflammation, Adaptive Thermogenesis and Lipolysis
- (2016) Verónica García-Alonso et al. PLoS One
- Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders
- (2015) Andreas Koeberle et al. BIOCHEMICAL PHARMACOLOGY
- Pharmacodynamic comparison of LY3023703, a novel microsomal prostaglandin e synthase 1 inhibitor, with celecoxib
- (2015) Y Jin et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- COX-2 is involved in vascular oxidative stress and endothelial dysfunction of renal interlobar arteries from obese Zucker rats
- (2015) Mercedes Muñoz et al. FREE RADICAL BIOLOGY AND MEDICINE
- Galectin-3 Participates in Cardiovascular Remodeling Associated With ObesityNovelty and Significance
- (2015) Ernesto Martínez-Martínez et al. HYPERTENSION
- Endothelial Dysfunction, Obesity and Insulin Resistance
- (2014) Dolores Prieto et al. Current Vascular Pharmacology
- Small Artery Remodeling in Obesity and Insulin Resistance
- (2014) Ana Briones et al. Current Vascular Pharmacology
- Myeloid cell microsomal prostaglandin E synthase-1 fosters atherogenesis in mice
- (2014) L. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prostaglandin E2signals white-to-brown adipogenic differentiation
- (2014) Verónica García-Alonso et al. Adipocyte
- Prevention of Obesity and Insulin Resistance by Estrogens Requires ER Activation Function-2 (ER AF-2), Whereas ER AF-1 Is Dispensable
- (2013) S. Handgraaf et al. DIABETES
- 2013 ESH/ESC Guidelines for the management of arterial hypertension
- (2013) Giuseppe Mancia et al. JOURNAL OF HYPERTENSION
- Mannheim Carotid Intima-Media Thickness and Plaque Consensus (200420062011)
- (2012) P.-J. Touboul et al. CEREBROVASCULAR DISEASES
- Microsomal Prostaglandin E 2 Synthase-1 Modulates the Response to Vascular Injury
- (2011) Miao Wang et al. CIRCULATION
- Evaluation of intima-media thickness and vascular elasticity of the common carotid artery in patients with isolated systolic hypertension using ultrasound radiofrequency-data technology
- (2011) Hai-Jun Dan et al. CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING
- Lack of microsomal prostaglandin E synthase-1 reduces cardiac function following angiotensin II infusion
- (2010) Pamela Harding et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Cyclooxygenase-2 Deficiency Attenuates Adipose Tissue Differentiation and Inflammation in Mice
- (2010) Sarbani Ghoshal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Oxidative stress and inflammatory mediators contribute to endothelial dysfunction in high-fat diet-induced obesity in mice
- (2010) Renata Kobayasi et al. JOURNAL OF HYPERTENSION
- Cyclooxygenase-2 Inhibition Restored Endothelium-Mediated Relaxation in Old Obese Zucker Rat Mesenteric Arteries
- (2010) Emilie Vessières et al. Frontiers in Physiology
- Estrogens Protect against High-Fat Diet-Induced Insulin Resistance and Glucose Intolerance in Mice
- (2009) Elodie Riant et al. ENDOCRINOLOGY
- Suppressive effect of COX2 inhibitor on the progression of adipose inflammation in high-fat-induced obese rats
- (2009) P.-S. Hsieh et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency
- (2009) Kathy Jaworski et al. NATURE MEDICINE
- Comparison of microsomal prostaglandin E synthase-1 deletion and COX-2 inhibition in acute cardiac ischemia in mice
- (2009) Dongmei Wu et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Microsomal Prostaglandin E 2 Synthase-1 Deletion Leads to Adverse Left Ventricular Remodeling After Myocardial Infarction
- (2008) Norbert Degousee et al. CIRCULATION
- Microsomal Prostaglandin E Synthase-1 Deletion Suppresses Oxidative Stress and Angiotensin II–Induced Abdominal Aortic Aneurysm Formation
- (2008) Miao Wang et al. CIRCULATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation